Toulouse, France

Patrick Gros-Claude

This inventor holds 2 USPTO granted patents. Top assignees: Sanofi-Aventis, Sanofi-Synthelabo. Active years: 2005-2006.


Average Co-Inventor Count = 2.9

ph-index = 1


Location History:

  • Berberaud, FR (2005)
  • Toulouse, FR (2006)

Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Patrick Gros-Claude

Introduction

Patrick Gros-Claude is a notable inventor based in Toulouse, France. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 2 patents to his name, Gros-Claude's work has had a meaningful impact on drug formulation and synthesis.

Latest Patents

Gros-Claude's latest patents include innovative processes and compounds. One of his notable inventions is related to crystalline forms of osanetant, specifically the crystalline forms of (R)-(+)-N-[[3-[1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4-yl]-N-methylacetamide. This invention focuses on the preparation methods for these crystalline forms. Another significant patent involves a method for preparing 4-methylamino-4-phenylpiperidine. This process entails the hydrolysis of 1-benzyl-4-cyano-4-phenylpiperidine in acidic medium and subsequent treatment with bromine in the presence of an alkali metal alkoxide.

Career Highlights

Throughout his career, Gros-Claude has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Sanofi-Aventis. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Gros-Claude has collaborated with several esteemed colleagues, including Gilles Anne-Archard and Alain Alcade. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Patrick Gros-Claude's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations highlight his commitment to advancing drug development. His work continues to influence the industry and inspire future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…